About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Microbiota Study in Liver Transplanted Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03507140

Microbiota Study in Liver Transplanted Patients

Many studies describe the relationship between microbiota alteration and the occurrence of metabolic, alcoholic or inflammatory liver diseases. Nevertheless, the modifications of microbiota during liv...

Lead sponsor: University Hospital, Grenoble•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Grenoble

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Recipients:
•Age ≥ 18 years old
•Absence of LT contraindications
•Patient undergoing liver transplantation
•Patient legally able to give written consent.
•Person affiliated to social security
•Donors:
•Cadaveric-donor liver transplantation

Exclusion Criteria

•Living-related liver transplantation
•LT contraindications
•All subjects protected by articles L1121-5 and L1121-8 of French public health law (Subject under administrative or judicial control, person who are protected under the act, person hospitalized without their consent, prisoners and pregnant or breast-feeding women).

Related studies

MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.

NCT07607769 · Hepatocellular Carcinoma

ADDICTOlogical Intervention in LIVEr Transplantation Recipients

NCT06472973 · Alcohol Associated Liver Disease, Liver Transplantation

RECRUITINGPhase 2

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

NCT07549503 · Liver Transplant

Efficacy and Safety of SIRT-Y90 in Combination With Atezo + Bev for Unresectable Hepatocellular Carcinoma

NCT07610551 · HCC - Hepatocellular Carcinoma

RECRUITINGPhase 2

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

NCT06280950 · Liver Transplant

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 20, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment64

Start dateApr 2019

Last updatedApr 20, 2025

Condition

Cirrhosis Hepatocellular Carcinoma Liver Transplant Microbiota

Locations shown

CHU de GRENOBLE ALPES

Grenoble

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 20, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions